Status:
UNKNOWN
Response Evaluation in Malignant Pleural Mesothelioma
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
Malignant Pleural Mesothelioma
Eligibility:
All Genders
18+ years
Brief Summary
Recently, a few small trials have shown promising results on value of fluoro-2-deoxy-D-glucose and positron emission tomography imaging in response assessment in Malignant Pleural Mesothelioma. These ...
Detailed Description
This is a retrospective analysis of two consecutive and homogeneous series of Malignant Pleural Mesothelioma patients treated with first-line pemetrexed-based chemotherapy and evaluated by CT scan and...
Eligibility Criteria
Inclusion
- Histologically proven MALIGNANT PLEURAL MESOTHELIOMA
- Patients not candidate to radical surgery
- Unidimensionally and/or bidimensionally CT-measurable disease and Candidate to first-line pemetrexed-based chemotherapy
Exclusion
- Histologically not proven MALIGNANT PLEURAL MESOTHELIOMA
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2015
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00969098
Start Date
June 1 2009
End Date
September 1 2015
Last Update
August 6 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Clinico Humanitas
Rozzano, Milano, Italy, 20089